enrofloxacin has been researched along with Campylobacter Infection in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Frizzo, LS; Olivero, CR; Rossler, E; Signorini, ML; Soto, LP; Zbrun, MV; Zimmermann, JA | 1 |
| Cernicchiaro, N; Nagaraja, TG; Renter, DG; Sahin, O; Shi, X; Smith, AB | 1 |
| Inglis, GD; Selinger, LB; Taboada, EN; Uwiera, RRE; Zaytsoff, SJM | 1 |
| Sakemi, Y; Tamura, Y; Uchida, I; Usui, M | 1 |
| Ge, B; Han, F; Lestari, SI; Pu, S | 1 |
| Fox, JG; Hurcombe, SD; Kohn, CW | 1 |
| Dickson, J; Holtkamp, D; Hurd, HS; Vaughn, MB; Warnick, L | 1 |
| Mansouri-najand, L; Saleha, AA; Wai, SS | 1 |
| Jung, J; Kim, M; Lee, Y; Oh, Y; Shin, E | 1 |
| Asai, T; Haruna, M; Ito, K; Mori, T; Murakami, M; Sasaki, Y; Yamada, Y | 1 |
| Lin, J; Luo, N; Michel, LO; Sahin, O; Zhang, Q | 1 |
| Avrain, L; Humbert, F; Kempf, I; L'Hospitalier, R; Sanders, P; Vernozy-Rozand, C | 1 |
| Blaser, MJ; Iovine, NM | 1 |
| Asai, T; Harada, K; Ishihara, K; Kojima, A; Takahashi, T; Tamura, Y | 1 |
| Cox, LA; Popken, DA | 1 |
| Cox, LA | 1 |
| Lucchi, A; Manfreda, G; Pasquali, F | 1 |
18 other study(ies) available for enrofloxacin and Campylobacter Infection
| Article | Year |
|---|---|
Possible reservoirs of thermotolerant Campylobacter at the farm between rearing periods and after the use of enrofloxacin as a therapeutic treatment.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Chickens; Disease Reservoirs; Enrofloxacin; Farms; Genotype; Poultry Diseases; Prevalence; Thermotolerance | 2021 |
Campylobacter Prevalence and Quinolone Susceptibility in Feces of Preharvest Feedlot Cattle Exposed to Enrofloxacin for the Treatment of Bovine Respiratory Disease.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cattle Diseases; Cross-Sectional Studies; Drug Resistance, Bacterial; Enrofloxacin; Kansas; Prevalence; Quinolones; Texas | 2018 |
Therapeutic administration of enrofloxacin in mice does not select for fluoroquinolone resistance in Campylobacter jejuni.
Topics: Animals; Campylobacter Infections; Campylobacter jejuni; Drug Resistance, Bacterial; Enrofloxacin; Feces; Fluoroquinolones; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests | 2018 |
Effects of fluoroquinolone treatment and group housing of pigs on the selection and spread of fluoroquinolone-resistant Campylobacter.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Drug Resistance, Bacterial; Enrofloxacin; Feces; Fluoroquinolones; Housing, Animal; Random Allocation; Swine; Swine Diseases | 2014 |
Prevalence and antimicrobial resistance among Campylobacter spp. in Louisiana retail chickens after the enrofloxacin ban.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Chickens; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Food Contamination; Microbial Sensitivity Tests; Poultry Diseases; Prevalence; Random Allocation | 2009 |
Isolation of Campylobacter fetus subspecies fetus in a two-year-old quarterhorse with chronic diarrhea of an undetermined etiology.
Topics: Animals; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Diarrhea; DNA, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Horse Diseases; Horses; Polymerase Chain Reaction; RNA, Ribosomal, 16S | 2009 |
Quantitative risk from fluoroquinolone-resistant Salmonella and Campylobacter due to treatment of dairy heifers with enrofloxacin for bovine respiratory disease.
Topics: Animals; Campylobacter Infections; Cattle; Cattle Diseases; Drug Resistance, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Foodborne Diseases; Humans; Meat; Respiratory Tract Diseases; Risk Factors; Salmonella Infections | 2010 |
Prevalence of multidrug resistance Campylobacter jejuni and Campylobacter coli in chickens slaughtered in selected markets, Malaysia.
Topics: Abattoirs; Animals; Bird Diseases; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cephalothin; Chickens; Cloaca; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Erythromycin; Fluoroquinolones; Food Microbiology; Gentamicins; Malaysia; Microbial Sensitivity Tests; Tetracycline | 2012 |
Antimicrobial resistance patterns and corresponding multilocus sequence types of the Campylobacter jejuni isolates from human diarrheal samples.
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Diarrhea; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Fluoroquinolones; Gastroenteritis; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Republic of Korea; Tetracycline; Virulence | 2013 |
Prevalence and antimicrobial resistance of Campylobacter isolates from beef cattle and pigs in Japan.
Topics: Animals; Campylobacter Infections; Campylobacter jejuni; Cattle; Cattle Diseases; Drug Resistance, Bacterial; Enrofloxacin; Erythromycin; Fluoroquinolones; Japan; Prevalence; Rectum; Swine; Swine Diseases | 2013 |
In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.
Topics: Animals; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2003 |
Antimicrobial resistance in Campylobacter from broilers: association with production type and antimicrobial use.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Chickens; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Erythromycin; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Poultry Diseases; Quinolones; Tetracycline | 2003 |
Antimicrobial resistance in Campylobacter.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Poultry Diseases; Quinolones | 2004 |
Emergence of fluoroquinolone resistance in Campylobacter jejuni in chickens exposed to enrofloxacin treatment at the inherent dosage licensed in Japan.
Topics: Animals; Campylobacter Infections; Campylobacter jejuni; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Japan; Microbial Sensitivity Tests; Poultry Diseases; Specific Pathogen-Free Organisms | 2005 |
Quantifying potential human health impacts of animal antibiotic use: enrofloxacin and macrolides in chickens.
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Food Contamination; Food Microbiology; Humans; Macrolides; Models, Biological; Risk Assessment; Safety; Veterinary Drugs | 2006 |
Enrofloxacin in poultry and human health.
Topics: Animals; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Poultry Diseases; Risk Factors; Zoonoses | 2006 |
Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry | 2008 |
FDA hastening withdrawal of fluoroquinolone approvals for poultry.
Topics: Animals; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Drug Approval; Enrofloxacin; Fluoroquinolones; Quinolones; Risk Assessment; Turkeys; United States; United States Food and Drug Administration | 2000 |